Attitudes of community pharmacists to ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Attitudes of community pharmacists to off-label prescribing of baclofen in northern france
Auteur(s) :
Auffret, Marine [Auteur]
Rolland, Benjamin [Auteur]
Caous, Anne-Sylvie [Auteur]
Deheul, Sylvie [Auteur]
Bene, Johana [Auteur]
Cottencin, Olivier [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Bordet, Regis [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Gautier, Sophie [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Rolland, Benjamin [Auteur]
Caous, Anne-Sylvie [Auteur]
Deheul, Sylvie [Auteur]
Bene, Johana [Auteur]
Cottencin, Olivier [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Bordet, Regis [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Gautier, Sophie [Auteur]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Titre de la revue :
International journal of clinical pharmacy
Nom court de la revue :
Int. J. Clin. Phar,.
Numéro :
37
Pagination :
296-299
Date de publication :
2015-04-01
ISSN :
2210-7703
Mot(s)-clé(s) en anglais :
Community pharmacists
Drug dispensing
France
Off-label
Baclofen
Alcohol dependence
Mesh:GABA-B Receptor Agonists/therapeutic use
Mesh:Humans
Mesh:Off-Label Use*
Mesh:Pharmacists/psychology*
Mesh:Surveys and Questionnaires
Mesh:Baclofen/therapeutic use*
Mesh:Attitude of Health Personnel*
Mesh:Alcoholism/epidemiology
Mesh:Alcoholism/drug therapy*
Mesh:Community Pharmacy Services*
Mesh:France/epidemiology
Drug dispensing
France
Off-label
Baclofen
Alcohol dependence
Mesh:GABA-B Receptor Agonists/therapeutic use
Mesh:Humans
Mesh:Off-Label Use*
Mesh:Pharmacists/psychology*
Mesh:Surveys and Questionnaires
Mesh:Baclofen/therapeutic use*
Mesh:Attitude of Health Personnel*
Mesh:Alcoholism/epidemiology
Mesh:Alcoholism/drug therapy*
Mesh:Community Pharmacy Services*
Mesh:France/epidemiology
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Sciences cognitives
Sciences cognitives
Résumé en anglais : [en]
BACKGROUND: Community pharmacists' liability is involved when they dispense off-label prescriptions (OLPs). However, their attitudes to off-label prescribing are little known, while in France off-label baclofen use for ...
Lire la suite >BACKGROUND: Community pharmacists' liability is involved when they dispense off-label prescriptions (OLPs). However, their attitudes to off-label prescribing are little known, while in France off-label baclofen use for alcohol dependence is increasing. OBJECTIVE: To determine community pharmacists' attitudes to off-label prescribing of baclofen. METHODS: A postal questionnaire was sent to 219 community pharmacies in the Nord-Pas-de-Calais region, France, previously identified as delivering at least five boxes of oral baclofen monthly. The questionnaire examined whether pharmacists delivered baclofen for alcohol dependence, how pharmacists detected off-label prescribing of baclofen, who were the most frequent prescribers (general practitioners or specialists), and pharmacists' attitudes to OLPs. RESULTS: Eighty pharmacies responded (36.5 %). Detection criteria for OLPs were supra-threshold dose (77.3 %) and "off-label" written on prescription (52.5 %). General practitioners were the most frequent prescribers of off-label baclofen. Pharmacists were more likely to refuse to fill prescriptions not marked "off-label" (6.0 %) than correctly marked prescriptions (1.5 %). 85 % of respondents considered they lacked information on off-label use. CONCLUSIONS: Although community pharmacists felt they were poorly informed on off-label baclofen, the majority nevertheless delivered the drug. Since our survey, off-label baclofen prescribing has been strictly controlled in France. Pharmacists' current attitudes will need further evaluation.Lire moins >
Lire la suite >BACKGROUND: Community pharmacists' liability is involved when they dispense off-label prescriptions (OLPs). However, their attitudes to off-label prescribing are little known, while in France off-label baclofen use for alcohol dependence is increasing. OBJECTIVE: To determine community pharmacists' attitudes to off-label prescribing of baclofen. METHODS: A postal questionnaire was sent to 219 community pharmacies in the Nord-Pas-de-Calais region, France, previously identified as delivering at least five boxes of oral baclofen monthly. The questionnaire examined whether pharmacists delivered baclofen for alcohol dependence, how pharmacists detected off-label prescribing of baclofen, who were the most frequent prescribers (general practitioners or specialists), and pharmacists' attitudes to OLPs. RESULTS: Eighty pharmacies responded (36.5 %). Detection criteria for OLPs were supra-threshold dose (77.3 %) and "off-label" written on prescription (52.5 %). General practitioners were the most frequent prescribers of off-label baclofen. Pharmacists were more likely to refuse to fill prescriptions not marked "off-label" (6.0 %) than correctly marked prescriptions (1.5 %). 85 % of respondents considered they lacked information on off-label use. CONCLUSIONS: Although community pharmacists felt they were poorly informed on off-label baclofen, the majority nevertheless delivered the drug. Since our survey, off-label baclofen prescribing has been strictly controlled in France. Pharmacists' current attitudes will need further evaluation.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Troubles cognitifs dégénératifs et vasculaires
Date de dépôt :
2019-11-27T13:33:37Z
2019-11-28T07:32:40Z
2019-11-28T07:32:40Z